ANDA 61829, held by Mylan. Ampicillin/Ampicillin Trihydrate.
As of Nov 15, 2026, ANDA 61829 (Ampicillin Trihydrate), held by Mylan, was not approved, with 0 approved supplements and 0 published complete response letters.
| Ampicillin TrihydrateEQ 250MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Ampicillin TrihydrateEQ 125MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
